Impact of Circulating and Tissue-specific Lipids on Vascular Function and Insulin Sensitivity in Chronic Night Shift Workers
Colorado State University · with University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI) · NCT06550115
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- March 1, 2024
- Record last updated
- December 17, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
People who experience repeated bouts of circadian misalignment, such as shift workers, are at higher risk of cardiovascular disease (CVD) and Type 2 diabetes (T2D) compared to daytime workers. However, the mechanism(s) by which shift work and associated circadian misalignment increase CVD and T2D risk are unknown. This project will examine whether elevated plasma lipids are a mechanism by which circadian misalignment impairs vascular function, insulin sensitivity, glucose homeostasis and muscle lipid accumulation, which could be targeted to prevent and treat cardiometabolic disease in people who chronically experience circadian misalignment, which includes more than 20% of the US workforce.
Being studied: Time-restricted eating; Control eating
Conditions: Circadian Rhythm Sleep Disorder of Shift Work Type; Metabolic Disease; Insulin Sensitivity; Blood Pressure
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18-65 years old
- worked the night shift for the last 1 year or more,
- habitually sleep 5-9 hours per 24h period (night shift workers typically experience chronic insufficient sleep),
- body mass index (BMI) of 20.0 - 35.0 kg/m2 and weight stable (plus or minus 5% of current body weight in the last 6 months); sedentary to mild physical activity level (less than 2 days of planned exercise per week);
Exclusion Criteria
- existing diagnosed sleep or eating disorder (e.g. obstructive sleep apnea [OSA], periodic limb movements of sleep [PLMS], narcolepsy, travel more than 1 time zone in 3 weeks before the study; anorexia nervosa, more than one food allergy to maintain flexibility in diet planning);
- following any TRE (time-restricted eating) or intermittent fasting plan in the last year;
- following any special diet plan, like paleo, keto, gluten-free or vegan, that can affect the primary lipid outcome measures in the last 6 months; any clinically significant surgical condition within the last year;
- diagnosed diabetes or cardiovascular disease
- The prevalence of insomnia in shift workers is fairly high, ranging from 12.8% to 76.4%, which is higher than estimated for the general population. Insomnia itself is associated with elevated neural cardiovascular responsiveness to stress compared to people without insomnia. Thus, since excessive sleepiness and symptoms of insomnia may be present in night shift workers they will not be exclusionary.
Recruiting US locations
Colorado State University
Fort Collins, CO 80523
Site contact: Ellen Lyon, MS · 970-491-3103 · ellen.lyon@colostate.edu
Study contacts (from the official record)
- Josiane L Broussard, PhD · 9704913103 · josiane.broussard@colostate.edu
- Ellen Lyon, MS · 9704913103 · ellen.lyon@colostate.edu
Similar studies in Colorado
All diabetes studies in Colorado →- RecruitingHealthy volunteers
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Cleerly, Inc.
- Location
- Aurora, CO + 121 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Merck Sharp & Dohme LLC
- Location
- Denver, CO + 27 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Medtronic MiniMed, Inc.
- Location
- Aurora, CO + 9 other US sites
- Eligibility basics
- Ages 2–80
- RecruitingPhase 2
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Boehringer Ingelheim
- Location
- Lakewood, CO + 21 other US sites
- Eligibility basics
- Ages 18+